Pharmaceutical companies stalling on plant construction plan

Published: 2011-09-29 06:57:00

Updated: 2011-09-29 06:57:00

Reflecting increasing uncertainty in the domestic pharmaceutical industry due to the government’s plan to cut drug prices starting next year, big corporations, Dong-A and Daewoong, are delaying the construction or re-modeling plan of their plants for next year.

They say that things are put on ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK